Diseases, Conditions, Syndromes

T cells fit to tackle Omicron, suggests new study

Research from the Hong Kong University of Science and Technology (HKUST) and the University of Melbourne has revealed that T cells, one of the body's key defenses against COVID-19, are expected to be effective in mounting ...

Genetics

Study identifies 'major player' in skin cancer genes

A multidisciplinary team at Yale, led by Yale Cancer Center members, has defined a subgroup of genetic mutations that are present in a significant number of melanoma skin cancer cases. Their findings shed light on an important ...

Diseases, Conditions, Syndromes

FDA-approved drug shows promise against ALS in mice

The cause of amyotrophic lateral sclerosis (ALS)—a disabling neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to weakened muscles and early death—is not fully understood, but accumulating ...

Parkinson's & Movement disorders

Vitamin K2: New hope for Parkinson's patients?

Neuroscientist Patrik Verstreken, associated with VIB and KU Leuven, succeeded in undoing the effect of one of the genetic defects that leads to Parkinson's using vitamin K2. His discovery gives hope to Parkinson's patients. ...

HIV & AIDS

Scientists map route for eliciting HIV-neutralizing antibodies

Researchers have traced in detail how certain powerful HIV neutralizing antibodies evolve, a finding that generates vital clues to guide the design of a preventive HIV vaccine, according to a study appearing in Science Express ...

Medical research

Discovery may lead to mitochndria syndrome treatment

Mitochondrial depletion syndrome accounts for about 11 percent of the cases of children born with common myopathies and a more mild form of the syndrome affecting adults. A new finding by Cornell researchers may lead to a ...

page 11 from 40